Concepedia

Elizabeth R. Tucker

ER

9

Publications

401

Citations

9

H-Index

1989

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Elizabeth R. Tucker is an author at Institute of Cancer Research specializing in public health, medicine, and obstetrics.

ORCID

Top concepts

Publications per year

1989–2023

9

Publications

9

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

Jikui Guan, Elizabeth R. Tucker, Haisu Wan et al. · Disease Models & Mechanisms · 2016 · 83 citations · Full text

Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity

Ellen Watts, David Heidenreich, Elizabeth R. Tucker et al. · Journal of Medicinal Chemistry · 2019 · 61 citations · Full text

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

Mareike Berlak, Elizabeth R. Tucker, Mathurin Dorel et al. · Molecular Cancer · 2022 · 57 citations · Full text

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors

Lynsey Vaughan, Paul A. Clarke, Karen Barker et al. · Oncotarget · 2016 · 53 citations · Full text

Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus

Sandra G. Gonzalez Malagon, Anna M. Lopez Muñoz, Daniel Doro et al. · Nature Communications · 2018 · 46 citations · Full text

Rows per page

1–5 of 9